The aim of this study was to assess the usefulness of ABCA1, ABCB7, ABCB1, APOE, CYP46A1, and LRP1 genotyping as promising dementia risk factors among a wide group of patients diagnosed first with hyperlipidemia. This evidence concerns the gene CYP46A1 and hyperlipidemia.